drug
raltegravir potassium
Marketedupdated 3mo agoby Lupin Ltd
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying raltegravir potassium
- phase3Renal Transplantation and Raltegravir in HIV-Infected Patients
- phase2Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
- phase2Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL
- phase2Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
- phase2Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy
- phase4A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
- phase3Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY
- phase4Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 28, 2028
~1.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (17)
- Mar 30, 2032method-of-use (U-1663)US 10772888
- Apr 21, 2031patentUS 9649311*PED4.7y
- Oct 21, 2030formulationUS 96493114.2y
- Jun 2, 2030compositionUS 87717333.8y
- Jun 2, 2030compositionUS 87717333.8y
- Jun 2, 2030compositionUS 87717333.8y
- Sep 11, 2029patentUS 7754731*PED3.1y
- Sep 11, 2029patentUS 7754731*PED3.1y
- Sep 11, 2029patentUS 7754731*PED3.1y
- Sep 11, 2029patentUS 7754731*PED3.1y
- Sep 11, 2029patentUS 7754731*PED3.1y
- Mar 11, 2029compositionUS 77547312.6y
- Mar 11, 2029compositionUS 77547312.6y
- Mar 11, 2029compositionUS 77547312.6y
- Mar 11, 2029compositionUS 77547312.6y
- Mar 11, 2029compositionUS 77547312.6y
- Jan 28, 2028compositionUS 88526321.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that